View Clause Headings                                                                                                                                               HelpHelp
DOCUMENT TITLE:  License and Transfer Agreement for IL-21 Protein .
ACTIONS: Here are the clause headings in the document. To view the clause, click the clause heading.To view the full document, click the "View Document" button.

View Document Back
Clause Heading
ARTICLE 2 - Data and Know-How Transfer
SECTION 2.1 - Transfer Activities.
SECTION 2.2 - Clinical Supply Transfer.
SECTION 2.3 - Oversight.
SECTION 2.4 - Costs of Manufacturing Process Transfer.
SECTION 2.5 - Assignment and Ownership of Approvals and Regulatory Submissions.
SECTION 2.6 - Ongoing Clinical Trials.
SECTION 2.7 - Clinical Data Publication.
SECTION 2.9 - Right to Submit Information Exchanged.
SECTION 2.10 - Data Protection.
SECTION 2.11 - Assistance and Cooperation.
SECTION 2.12 - Cooperation and Transfer Obligations.
SECTION 3.1 - Ownership of Intellectual Property.
SECTION 3.2 - License.
SECTION 3.3 - Reservation of Right.
SECTION 3.7 - Notice of Infringement and Conference.
SECTION 3.8 - Enforcement of ZGEN Prosecuted Patents.
SECTION 3.9 - Monetary Awards.
SECTION 3.10 - Enforcement of NN Prosecuted Patents.
SECTION 3.11 - Cooperation.
SECTION 3.12 - Affiliates, Commercialization Partners and Sublicensees.
SECTION 4.1 - Diligence Obligations.
SECTION 4.2 - Milestone Fees.
SECTION 4.3 - Royalties on Patent Products.
SECTION 4.4 - Royalties on Know-How Products.
SECTION 4.5 - Not Additive.
SECTION 4.6 - No Royalty Offsets.
SECTION 4.7 - Payments and Reports.
SECTION 4.8 - Taxation of Payments.
SECTION 4.9 - Currency Blockage.
ARTICLE 5 - Excess RoW Royalty and Milestone Revenue Share
SECTION 5.2 - RoW Net Development Milestones Revenue Share.
SECTION 5.3 - RoW Net Sales Milestones Revenue Share.
SECTION 5.4 - Payments Due.
SECTION 5.5 - Good Faith Efforts.
SECTION 5.6 - Payments and Reports.
SECTION 6.1 - Confidentiality Obligation.
SECTION 7.3 - Insurance.
SECTION 8.1 - Term and Expiration.
SECTION 7.1 - Indemnification by ZGEN.
SECTION 7.2 - Indemnification by NN for Ongoing Clinical Trials.
SECTION 8.2 - Non-Viability.
SECTION 8.3 - Termination for Insolvency.
SECTION 8.4 - Termination for Material Breach.
SECTION 8.5 - Effect of Expiration or Termination.
SECTION 8.6 - Return of Technical Information.
SECTION 9.1 - Representations, Warranties and Covenants of NN.
SECTION 9.2 - Representations, Warranties and Covenants of ZGEN.
SECTION 9.3 - Warranty Disclaimer.
SECTION 9.4 - Limited Liability.
SECTION 10.1 - Assignment.
SECTION 10.2 - Assignment of Payments.
SECTION 10.3 - Relationship between the Parties.
SECTION 10.4 - Public Announcements.
SECTION 10.5 - Use of Names, Trade Names and Trademarks.
SECTION 10.6 - Force Majeure.
SECTION 10.7 - Governing Law.
SECTION 10.8 - Dispute resolution.
SECTION 10.9 - Waiver of Remedies.
SECTION 10.10 - Amendment and Waivers.
SECTION 10.11 - Entire Agreement.
SECTION 10.12 - Notices.
SECTION 10.13 - Severability.
SECTION 10.14 - Headings.
SECTION 10.15 - Review of Agreement.
SECTION 10.16 - Compliance with Laws; Export Regulations.
SECTION 10.17 - Expenses.
SECTION 10.18 - Counterparts.